217326-69-7

Basic information

• Product Name: 4-BroMo-2-Methyl-1,3-benzoxazole
• Synonyms: 4-BroMo-2-Methyl-1,3-benzoxazole;4-bromo-2-methylbenzo[d]oxazole;4-bromo-2-methylBenzoxazole;PCDOABUEJUJMKB-UHFFFAOYSA-N
• CAS NO: 217326-69-7
• Molecular Formula: C8H6BrNO
• Molecular Weight: 212.04334
• Mol File: 217326-69-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 264.8±13.0 °C(Predicted)
• Appearance: /
• Density: 1.606±0.06 g/cm3(Predicted)
• PKA: -1.31±0.30(Predicted)
• CAS DataBase Reference: 4-BroMo-2-Methyl-1,3-benzoxazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-2-Methyl-1,3-benzoxazole(217326-69-7)
• EPA Substance Registry System: 4-BroMo-2-Methyl-1,3-benzoxazole(217326-69-7)

Safety Data

• Hazardous Substances Data: 217326-69-7(Hazardous Substances Data)

Upstream product

• 614-76-6 N-acetyl-2-bromoaniline 
• 615-36-1 2-bromoaniline 
• 116435-77-9 2-amino-3-bromophenol 
• 78-39-7 Triethyl orthoacetate 

Relevant articles and documents

PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES AS SELECTIVE INHIBITOR OF CYCLIN DEPENDENT KINASE

The present invention relates to pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[l,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferative diseases, inflammatory diseases, immunological diseases, cardiovascular diseases and infectious diseases. Furthermore, the present invention is directed towards pharmaceutical compositions containing at least one of the pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof.

Biarylalkanoic acids as cell adhesion inhibitors

Compounds of Formula I are antagonists of VLA-4 and/or α4β7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.